Clinical trial
Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05526443 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
- Lead sponsor
- Medical University of Graz
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 13, 2023
- Completion date
- December 31, 2027
- Enrollment
- 1,500 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
advanced pancreatic carcinoma, pancreatic cancer